Skip to main content
Amrita Krishnan, MD, Oncology, Irvine, CA

Amrita Krishnan MD

Oncology•Irvine, CA

Hematologic Oncology

Director Multiple Myeloma Program: Professor of Medicine

Join to View Full Profile

  • 1000 FivePointIrvine, CA 92618

  • Phone+1 949-999-8979

  • Fax+1 626-389-3061

Dr. Krishnan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Krishnan's Full ProfileAlready have an account?

Summary

  • Dr. Amrita Krishnan is an oncologist in Irvine, CA and is affiliated with City of Hope Comprehensive Cancer Center. She received her medical degree from Albany Medical College and has been in practice 27 years. She specializes in hematologic oncology and is experienced in mitral valve prolapse, amyloidosis, hematopoietic stem cell transplantation, bone marrow transplantation, and multiple myeloma. She has more than 100 publications and over 500 citings.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
  • University of Rochester Medical Center
    University of Rochester Medical CenterResidency, Internal Medicine, 1990 - 1993
  • Albany Medical College
    Albany Medical CollegeClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - 2027
  • NY State Medical License
    NY State Medical License 1991 - 1994
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Lo...
    Amrita Y. Krishnan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Proteasome Inhibitors Impair the Innate Antiviral Immune Response and Potentiate Pelareorep-Based Viral Therapy in Multiple Myeloma
    Amrita Y. Krishnan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Current Obstacles in Myeloma Management: Debating the Evidence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • First-in-Human Imaging of Multiple Myeloma Using Copper-64-Labeled Daratumumab: Preliminary Results 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • CD84: A Potential Novel Therapeutic Target in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • City of Hope to Present Latest Research on Breast Cancer, Supportive Care, Kidney Cancer, and More at 2025 ASCO Annual Meeting
    City of Hope to Present Latest Research on Breast Cancer, Supportive Care, Kidney Cancer, and More at 2025 ASCO Annual MeetingMay 7th, 2025
  • How to Build a Successful Outpatient CAR T Cell Therapy Program
    How to Build a Successful Outpatient CAR T Cell Therapy ProgramApril 30th, 2025
  • Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-Escalation
    Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-EscalationDecember 28th, 2024
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Amrita Krishnan, Dr. Amrita Krishnan, MD, Dr. A Krishnan